Zentalis Pharmaceuticals
ZNTL
#9239
Rank
NZ$0.17 B
Marketcap
NZ$2.47
Share price
1.06%
Change (1 day)
-60.36%
Change (1 year)

Earnings for Zentalis Pharmaceuticals (ZNTL)

Earnings in 2025 (TTM): -NZ$0.26 Billion

According to Zentalis Pharmaceuticals's latest financial reports the company's current earnings are NZ$26.86 Million. In 2024 the company made an earning of -NZ$0.29 Billion, an increase over its 2023 earnings that were of -NZ$0.48 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Zentalis Pharmaceuticals from 2019 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$0.26 Billion-8.74%
2024 -NZ$0.29 Billion-40.16%
2023 -NZ$0.48 Billion25.12%
2022 -NZ$0.39 Billion34.48%
2021 -NZ$0.29 Billion39.33%
2020 -NZ$0.21 Billion154.74%
2019 -NZ$79.68 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Onconova Therapeutics
ONTX
-NZ$31.21 Million-87.86%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
-NZ$0.28 Billion 6.66%๐Ÿ‡บ๐Ÿ‡ธ USA